Our website, archdigest.com, offers constant original coverage of the interior design and architecture worlds, new shops and products, travel destinations, art and cultural events, celebrity style ...

Asklepios Biopharmaceutical (Askbio) has dosed the first participant in the second group of a Phase 1/2 trial testing AB-1003, an experimental gene therapy for limb-girdle muscular dystrophy (LGMD) ...